Adolescent Depression Clinical Trial
— AMPTOfficial title:
Probing the Neurophysiological Mechanisms Underlying Sex-specific Testosterone-mood Relationships During Puberty: A Randomized Controlled Trial Using a Smartphone-based Training Program
NCT number | NCT06072677 |
Other study ID # | 23-1336 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 24, 2023 |
Est. completion date | December 2027 |
Starting at puberty, female adolescents are nearly three-times more likely to develop internalizing disorders, like depression, while male adolescents are two-times more likely to develop externalizing disorders, like attention deficit hyperactivity disorder (ADHD). This divergence between the sexes during puberty suggests sex-specific pathways of risk and differential effects of sex hormones. The purpose of this research is to determine: 1) sex-specific neural and endocrine features of the pubertal transition that may mediate sex differences in adolescent mood disorders, and 2) the neurophysiological basis of susceptibility to hormone change during puberty.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 2027 |
Est. primary completion date | December 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 11 Years to 14 Years |
Eligibility | Inclusion Criteria: - Between the ages of 11 and 14 - Have their own personal mobile device and capability to download the MyCap and Healthy Minds apps - Experienced a stressful life event within the last year, or endorse moderate depression (defined by a CES-DC score 16 or higher) Exclusion Criteria: - Previous experience with the Healthy Minds Program - Regular meditation practice - Current or history of manic episodes, psychotic symptoms, or current suicidal intent - Taking any form of exogenous hormones or intrauterine device (IUD) within one month of participation in the study - Taking medications that directly alter cardiovascular or neurological function |
Country | Name | City | State |
---|---|---|---|
United States | Carolina Crossing B, Suite 1 | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill | Foundation of Hope, North Carolina |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CES-DC Score Over Time | The 20-item Center for Epidemiological Studies Depression Scale for Children (CES-DC) will be the primary measure of severity of depressive symptoms. Each item is rated 0 (not at all) to 3 (a lot), with items 4, 8, 12, and 16 being reversed scored. The total CES-DC score may range from 0-60. Higher scores indicate more severe depressive symptoms. Scores of 15 or greater are suggestive of significant depressive symptoms. The overall CES-DC score will be assessed at the end of each week in the study. | up to Week 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00399776 -
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
|
N/A | |
Completed |
NCT04603053 -
Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT
|
N/A | |
Completed |
NCT01802437 -
An Adaptive Treatment Strategy for Adolescent Depression
|
Phase 1/Phase 2 | |
Completed |
NCT06325605 -
Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression
|
N/A | |
Completed |
NCT02017535 -
An Adaptive Treatment Strategy for Adolescent Depression-Continuation
|
Phase 1/Phase 2 | |
Completed |
NCT03154008 -
Predictors of Response to Treatment for Depression
|
N/A | |
Recruiting |
NCT04613453 -
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
|
Phase 2 | |
Terminated |
NCT00284791 -
Lamotrigine in Treatment Resistant Depression in Adolescents
|
N/A | |
Completed |
NCT00312897 -
Omega-3 Fatty Acids in Adolescent Depression
|
Phase 2 | |
Recruiting |
NCT01857518 -
Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study
|
N/A | |
Recruiting |
NCT01170520 -
Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents
|
Phase 1/Phase 2 |